These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1120 related items for PubMed ID: 9825576

  • 41. Treatment results of three consecutive Brazilian cooperative childhood ALL protocols: GBTLI-80, GBTLI-82 and -85. ALL Brazilian Group.
    Brandalise S, Odone V, Pereira W, Andrea M, Zanichelli M, Aranega V.
    Leukemia; 1993 Aug; 7 Suppl 2():S142-5. PubMed ID: 8361220
    [Abstract] [Full Text] [Related]

  • 42. Acute lymphoblastic leukemia in children below two years of age.
    Derulska D, Rokicka-Milewska R, Lewicki Z, Jackowska T, Armata J, Bogusławska-Jaworska J, Chybicka A, Kubiczek K, Ochocka M, Radwańska U.
    Acta Haematol Pol; 1990 Aug; 21(1):1-9. PubMed ID: 2260400
    [Abstract] [Full Text] [Related]

  • 43. Allogeneic BMT versus autologous BMT in childhood acute lymphoblastic leukemia (ALL): an Italian cooperative study of vincristine (VCR), F-TBI and cyclophosphamide. AIEOP (Associazione Italiana Ematologia ed Oncologia Pediatrica) Italy.
    Uderzo C, Coleselli P, Messina C, Dini G, Bonetti F, Andolina M, Bagnulo S, Miniero R, Rondelli R, Paolucci P.
    Bone Marrow Transplant; 1991 Aug; 7 Suppl 2():132. PubMed ID: 1878677
    [No Abstract] [Full Text] [Related]

  • 44. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Grenzebach J, Schrappe M, Ludwig WD, Parwaresch R, Zimmermann M, Gadner H, Riehm H, Reiter A, BFM-Group.
    Ann Hematol; 2001 Aug; 80 Suppl 3():B73-6. PubMed ID: 11757713
    [Abstract] [Full Text] [Related]

  • 45. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
    Einsiedel HG, von Stackelberg A, Hartmann R, Fengler R, Schrappe M, Janka-Schaub G, Mann G, Hählen K, Göbel U, Klingebiel T, Ludwig WD, Henze G.
    J Clin Oncol; 2005 Nov 01; 23(31):7942-50. PubMed ID: 16258094
    [Abstract] [Full Text] [Related]

  • 46. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U, Harms DO, Schlüter S, Jorch N, Spaar HJ, Nürnberger W, Völpel S, Gutjahr P, Schrappe M, Janka G, Kabisch H.
    Klin Padiatr; 2000 Nov 01; 212(4):169-73. PubMed ID: 10994545
    [Abstract] [Full Text] [Related]

  • 47. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
    Ziino O, Russo D, Orlando MA, Benigno V, Locatelli F, Aricò M.
    Med Pediatr Oncol; 2002 Jul 01; 39(1):32-4. PubMed ID: 12116076
    [Abstract] [Full Text] [Related]

  • 48. BFM-oriented treatment for children with acute lymphoblastic leukemia without cranial irradiation and treatment reduction for standard risk patients: results of DCLSG protocol ALL-8 (1991-1996).
    Kamps WA, Bökkerink JP, Hakvoort-Cammel FG, Veerman AJ, Weening RS, van Wering ER, van Weerden JF, Hermans J, Slater R, van den Berg E, Kroes WG, van der Does-van den Berg A.
    Leukemia; 2002 Jun 01; 16(6):1099-111. PubMed ID: 12040440
    [Abstract] [Full Text] [Related]

  • 49. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Rivera-Luna R, Cardenas-Cardos R, Leal-Leal C, Navarro-Alegría I, Meza-Coria C, Gómez-Martínez R, Vega-Vega L.
    Arch Med Res; 1997 Jun 01; 28(2):233-9. PubMed ID: 9204615
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.
    Laver JH, Kraveka JM, Hutchison RE, Chang M, Kepner J, Schwenn M, Tarbell N, Desai S, Weitzman S, Weinstein HJ, Murphy SB.
    J Clin Oncol; 2005 Jan 20; 23(3):541-7. PubMed ID: 15659500
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [Improved treatment results in children with AML: Results of study AML-BFM 93].
    Creutzig U, Berthold F, Boos J, Fleischhack G, Gadner H, Gnekow A, Graubner U, Henze G, Hermann J, Imbach P, Jürgens H, Kabisch H, Körholz D, Niemeyer CM, Reinhardt D, Reiter A, Ritter J, Spaar HJ, Zimmermann M, AML-BFM-Studien-Gruppe.
    Klin Padiatr; 2001 Jan 20; 213(4):175-85. PubMed ID: 11528551
    [Abstract] [Full Text] [Related]

  • 56. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.
    Conter V, Aricò M, Basso G, Biondi A, Barisone E, Messina C, Parasole R, De Rossi G, Locatelli F, Pession A, Santoro N, Micalizzi C, Citterio M, Rizzari C, Silvestri D, Rondelli R, Lo Nigro L, Ziino O, Testi AM, Masera G, Valsecchi MG, Associazione Italiana di Ematologia ed Oncologia Pediatrica.
    Leukemia; 2010 Feb 20; 24(2):255-64. PubMed ID: 20016536
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [The Munich study on the treatment of acute lymphoblastic leukemia in childhood (ALL 77-02)].
    Graubner UB, Haas RJ, Janka G, Gaedicke G, Kohne E, Rieber EP.
    Klin Padiatr; 1985 Feb 20; 197(3):207-14. PubMed ID: 3892149
    [Abstract] [Full Text] [Related]

  • 59. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B, Bode U, von Schweinitz D.
    Klin Padiatr; 2003 Feb 20; 215(3):159-65. PubMed ID: 12778356
    [Abstract] [Full Text] [Related]

  • 60. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS, Holdsworth MT, Devidas M, Raisch DW, Chauvenet A, Ravindranath Y, Ducore JM, Amylon MD.
    Pediatr Blood Cancer; 2006 Feb 20; 46(2):179-86. PubMed ID: 16007607
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.